OppenheimerFunds’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

OppenheimerFunds’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-50,661	Closed	-$1.24M	–	1873
2017 Q4	$1.24M	Buy	+50,661	New	+$974K	﹤0.01%	1090

OppenheimerFunds's ENTL Position: Q1 2018 in Review

OppenheimerFunds sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 50,661 shares — an estimated $1.24M sold.

OppenheimerFunds first reported a position in ENTL in Q4 2017 and held it in 1 quarter. The position peaked at $1.24M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

OppenheimerFunds reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
OppenheimerFunds sold 50,661 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $1.24M.
OppenheimerFunds first reported a position in Entellus Medical, Inc. Common Stock in Q4 2017 and held it in 1 quarter.
OppenheimerFunds's Entellus Medical, Inc. Common Stock position peaked at $1.24M in Q4 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on OppenheimerFunds's 13F filing for Q1 2018, filed 11 May 2018.